Walmart is expanding its abortion coverage for employees after following the Supreme Court ruling that scrapped a nationwide right to abortion.
In a memo sent to employees, Walmart, the largest employer in the US, said its health care plans will now cover abortion for employees when there is rape or incest, or there is a health risk to the mother, ectopic pregnancy, miscarriage, or lack of fetal viability.
Walmart’s benefits plan had covered abortion only in cases when the health of the mother would be in danger if the fetus were carried to term, if the fetus could not survive the birthing process, or if death would be imminent after birth.
According to Walmart’s chief people officer, Donna Morris, the new policy will also offer “travel support” for workers seeking abortions covered under its health care plans, as well as their dependents, to enable them to access services that are not available within 100 miles of their locations.
Abortion is illegal in Arkansas, where the company is based unless it is required to save the mother's life in the event of a medical emergency.
The revised policy allows Walmart employees to travel outside of the state or any other state that prohibits abortion for rape and incest to obtain the procedure through the retailer's health plans.
In the United States, Walmart employs nearly 1.6 million people.


Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
California Sues Trump Administration Over Federal Authority on Sable Offshore Pipelines
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Supreme Court Signals Skepticism Toward Hawaii Handgun Carry Law
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 



